REQUEST A DEMO
Total
USD $0.00
Search more companies

Eli Lilly Romania SRL (Romania)

Main Activities: Administrative Management and General Management Consulting Services
Full name: Eli Lilly Romania SRL Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Eli Lilly Romania SRL company operates on the Romanian market since 2004. The main activity of the company is activities of business and management consultancy, and the company operates mostly in Bucharest. Worldwide, Lilly´s medicines are currently treating schizophrenia, diabetes, bipolar disorder, stress urinary incontinence, erectile dysfunction, depression, cancer, heart disease, pain, infections and gastric disorders and bringing relief to millions of people.

Headquarters
Strada Menuetului Nr. 12
Bucharest; Bucharest; Postal Code: 070000

Contact Details: Purchase the Eli Lilly Romania SRL report to view the information.

Basic Information
Total Employees:
Purchase the Eli Lilly Romania SRL report to view the information.
Registered Capital:
Purchase the Eli Lilly Romania SRL report to view the information.
Financial Auditors:
Purchase the Eli Lilly Romania SRL report to view the information.
Incorporation Date:
April 21, 2004
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Eli Lilly Romania SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
19.98%
Total operating revenue
20.02%
Operating profit (EBIT)
20.44%
EBITDA
19.72%
Net Profit (Loss) for the Period
22.38%
Total Assets
23.37%
Total Equity
28.48%
Operating Profit Margin (ROS)
0.03%
Net Profit Margin
0.06%
Return on Equity (ROE)
-0.58%
Quick Ratio
0.28%
Cash Ratio
0.33%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?